Based on this fact, in brain-metastatic HER2-positive breast cancer cells, PI3K/AKT signaling might be activated in the in vivo brain microenvironment, or there might be other mechanisms for cell growth in the brain parenchyma. This evidence concerns the gene PIK3CA and breast carcinoma.